2024 J Control Release
CagriSema produced 24.2% mean weight loss at 68 weeks compared to 5.8% with placebo
Recognizing these changes early and addressing them through integrative careincluding peptides , nutritional optimization , and hormone support can make all the difference
#ObesityMedicine #MetabolicHealth #PrecisionMedicine #Endocrinology #GLP1 #Tirzepatide #Semaglutide #BariatricSurgery #ChronicDisease #HealthcareInnovation #LifestyleMedicine To view or add a comment, sign in OBESITY NEWS Recent press release by Novo Nordisk highlights interesting points CHRONIC DISEASE Obesity should be approached as a chronic, progressive, and multifactorial disease, not as a matter of willpower
Incretin-based drugs are medications that mimic or enhance the action of incretin hormones, which are naturally released by the gut after eating to help regulate blood sugar and appetite
Choose an injection site on your abdomen (at least two inches from your belly button), thigh, or back of your upper armareas with adequate subcutaneous fat layer